NCT02856750View on ClinicalTrials.gov

Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 23, 2018

Study Completion Date

October 23, 2018

Conditions
Acute Pain
Interventions
DRUG

Gabapentin

Gabapentin 300 mg three times daily x30 days

Trial Locations (1)

80204

Denver Health Medical Center, Denver

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

Denver Health and Hospital Authority

OTHER

NCT02856750 - Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures | Biotech Hunter | Biotech Hunter